These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 24253788

  • 1. Prospective, randomized, controlled trial of silicate-substituted calcium phosphate versus rhBMP-2 in a minimally invasive transforaminal lumbar interbody fusion.
    Nandyala SV, Marquez-Lara A, Fineberg SJ, Pelton M, Singh K.
    Spine (Phila Pa 1976); 2014 Feb 01; 39(3):185-91. PubMed ID: 24253788
    [Abstract] [Full Text] [Related]

  • 2. Clinical sequelae after rhBMP-2 use in a minimally invasive transforaminal lumbar interbody fusion.
    Singh K, Nandyala SV, Marquez-Lara A, Cha TD, Khan SN, Fineberg SJ, Pelton MA.
    Spine J; 2013 Sep 01; 13(9):1118-25. PubMed ID: 24029138
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness and safety of recombinant human bone morphogenetic protein-2 versus local bone graft in primary lumbar interbody fusions.
    Adams CL, Ogden K, Robertson IK, Broadhurst S, Edis D.
    Spine (Phila Pa 1976); 2014 Jan 15; 39(2):164-71. PubMed ID: 24153173
    [Abstract] [Full Text] [Related]

  • 4. Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2 versus autograft.
    Khan TR, Pearce KR, McAnany SJ, Peters CM, Gupta MC, Zebala LP.
    Spine J; 2018 Mar 15; 18(3):439-446. PubMed ID: 28822825
    [Abstract] [Full Text] [Related]

  • 5. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
    Haid RW, Branch CL, Alexander JT, Burkus JK.
    Spine J; 2004 Mar 15; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
    [Abstract] [Full Text] [Related]

  • 6. Comparison of TLIF with rhBMP-2 versus no TLIF and higher posterolateral rhBMP-2 dose at L5-S1 for long fusions to the sacrum with sacropelvic fixation in patients with primary adult deformity.
    Rahman RK, Buchowski JM, Stephens B, Dorward IG, Koester LA, Bridwell KH.
    Spine (Phila Pa 1976); 2013 Dec 15; 38(26):2264-71. PubMed ID: 24108280
    [Abstract] [Full Text] [Related]

  • 7. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 1: Large series diagnosis related outcomes and complications with 2- to 9-year follow-up.
    Crandall DG, Revella J, Patterson J, Huish E, Chang M, McLemore R.
    Spine (Phila Pa 1976); 2013 Jun 01; 38(13):1128-36. PubMed ID: 23370679
    [Abstract] [Full Text] [Related]

  • 8. Nerve injury and recovery after lateral lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a cohort-controlled study.
    Lykissas MG, Aichmair A, Sama AA, Hughes AP, Lebl DR, Cammisa FP, Girardi FP.
    Spine J; 2014 Feb 01; 14(2):217-24. PubMed ID: 24269858
    [Abstract] [Full Text] [Related]

  • 9. The effect of recombinant human bone morphogenetic protein-2 in single-level posterior lumbar interbody arthrodesis.
    Michielsen J, Sys J, Rigaux A, Bertrand C.
    J Bone Joint Surg Am; 2013 May 15; 95(10):873-80. PubMed ID: 23677353
    [Abstract] [Full Text] [Related]

  • 10. Graft resorption with the use of bone morphogenetic protein: lessons from anterior lumbar interbody fusion using femoral ring allografts and recombinant human bone morphogenetic protein-2.
    Pradhan BB, Bae HW, Dawson EG, Patel VV, Delamarter RB.
    Spine (Phila Pa 1976); 2006 May 01; 31(10):E277-84. PubMed ID: 16648733
    [Abstract] [Full Text] [Related]

  • 11. A comparison of radiographic and clinical outcomes of anterior lumbar interbody fusion performed with either a cellular bone allograft containing multipotent adult progenitor cells or recombinant human bone morphogenetic protein-2.
    Lee DD, Kim JY.
    J Orthop Surg Res; 2017 Aug 25; 12(1):126. PubMed ID: 28841904
    [Abstract] [Full Text] [Related]

  • 12. Minimally invasive transforaminal lumbar interbody fusion: one surgeon's learning curve.
    Nandyala SV, Fineberg SJ, Pelton M, Singh K.
    Spine J; 2014 Aug 01; 14(8):1460-5. PubMed ID: 24290313
    [Abstract] [Full Text] [Related]

  • 13. A prospective, multi-institutional comparative effectiveness study of lumbar spine surgery in morbidly obese patients: does minimally invasive transforaminal lumbar interbody fusion result in superior outcomes?
    Adogwa O, Carr K, Thompson P, Hoang K, Darlington T, Perez E, Fatemi P, Gottfried O, Cheng J, Isaacs RE.
    World Neurosurg; 2015 May 01; 83(5):860-6. PubMed ID: 25535070
    [Abstract] [Full Text] [Related]

  • 14. Radiographic Appearance of Transforaminal Lumbar Interbody Fusion Performed With and Without Recombinant Human Morphogenetic Protein-2.
    Stensby JD, Kaliney RW, Alford B, Shen FH, Patrie JT, Fox MG.
    AJR Am J Roentgenol; 2016 Mar 01; 206(3):588-94. PubMed ID: 26901016
    [Abstract] [Full Text] [Related]

  • 15. Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion.
    Chen NF, Smith ZA, Stiner E, Armin S, Sheikh H, Khoo LT.
    J Neurosurg Spine; 2010 Jan 01; 12(1):40-6. PubMed ID: 20043763
    [Abstract] [Full Text] [Related]

  • 16. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 2: BMP dosage-related complications and long-term outcomes in 509 patients.
    Crandall DG, Revella J, Patterson J, Huish E, Chang M, McLemore R.
    Spine (Phila Pa 1976); 2013 Jun 01; 38(13):1137-45. PubMed ID: 23354111
    [Abstract] [Full Text] [Related]

  • 17. Long-term durability of minimal invasive posterior transforaminal lumbar interbody fusion: a clinical and radiographic follow-up.
    Rouben D, Casnellie M, Ferguson M.
    J Spinal Disord Tech; 2011 Jul 01; 24(5):288-96. PubMed ID: 20975594
    [Abstract] [Full Text] [Related]

  • 18. Revision surgery after interbody fusion with rhBMP-2: a cautionary tale for spine surgeons.
    Rodgers SD, Marascalchi BJ, Grobelny BT, Smith ML, Samadani U.
    J Neurosurg Spine; 2013 Jun 01; 18(6):582-7. PubMed ID: 23560709
    [Abstract] [Full Text] [Related]

  • 19. RhBMP-2 versus iliac crest bone graft for lumbar spine fusion: a randomized, controlled trial in patients over sixty years of age.
    Glassman SD, Carreon LY, Djurasovic M, Campbell MJ, Puno RM, Johnson JR, Dimar JR.
    Spine (Phila Pa 1976); 2008 Dec 15; 33(26):2843-9. PubMed ID: 19092613
    [Abstract] [Full Text] [Related]

  • 20. RhBMP-2-induced radiculitis in patients undergoing transforaminal lumbar interbody fusion: relationship to dose.
    Villavicencio AT, Burneikiene S.
    Spine J; 2016 Oct 15; 16(10):1208-1213. PubMed ID: 27343729
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.